Search results
Patriots OTA observations: Maye makes minor leap during choppy session
NBC Sports Boston via Yahoo Sports· 4 hours ago...Here is the full list of Tuesday's absentees: Matthew Judon, OLB Mike Onwenu, OL Chukwuma...
With post-June 1 salary cap space, Cowboys have options if willing to spend
WFAA Dallas-Fort Worth· 16 hours agoWhen it comes to adding free agents, it’s been a slow offseason for the Dallas Cowboys. Upper...
PFF projects Colts’ starting lineup on defense for 2024 season
Colts Wire via Yahoo Sports· 19 hours ago...Buckner DI: Grover Stewart Edge: Samson Ebukam Edge: Kwity Paye Edge: Laiatu Latu LB: Zaire...
WATCH: Baker Mayfield talks Bucs OTAs, new offense and more
Buccaneers Wire via Yahoo Sports· 13 hours agoJ.J. Russell (Photo by Mike Carlson/Getty Images) Share Share this image gallery on Facebook on...
Eagles practice observations: Kelee Ringo in the CB conversation; Dropping edges in Vic Fangio’s...
Philly.com· 9 hours agoThe Eagles held their first practice of a three-day minicamp on Tuesday at the NovaCare Complex....
Chubb (CB) Stock Moves -0.42%: What You Should Know
Zacks via Yahoo Finance· 6 days agoIn the latest market close, Chubb (CB) reached $261.53, with a -0.42% movement compared to the previous day. The stock outperformed the S&P 500, which...
Here is What to Know Beyond Why Chubb Limited (CB) is a Trending Stock
Zacks via Yahoo Finance· 7 days agoChubb (CB) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might...
Wisconsin Football Hosting Blue-Chip 2026 CB for Campus BBQ
Athlon Sports· 17 hours agoThe Badgers will have one of the nation's top 2026 CBs on campus for a visit in June. A blue-chip,...
Christian Parker Calls Eagles' Veteran CB 'Motivated'
Sports Illustrated· 1 day agoThe NFL’s afternoon wire featured a couple of transactions by the Eagles, both of them procedural....
Small Business - Picayune Item | Picayune Item
The Picayune Item· 2 days ago-- CB-010 allogeneic CAR-T cell therapy with partial HLA matching has potential to rival efficacy and safety profile of approved autologous CAR-T cell therapies -- -- 14.4 ...
